YMRC
HALO icon

Yorktown Management & Research Company’s Halozyme HALO Stock Holding History

Yorktown Management & Research Company’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$614K Buy
7,850
+3,400
+76% +$232K 0.38% 93
2026
Q1 		$288K Buy
+4,450
New +$314K 0.24% 164

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return

Yorktown Management & Research Company's HALO Position: Q2 2026 in Review

Yorktown Management & Research Company increased its Halozyme (HALO) stake by 76% in Q2 2026, buying an estimated $232K and bringing the position to 7,850 shares worth $614K. The position accounts for 0.38% of the portfolio, ranked #93.

Yorktown Management & Research Company first reported a position in HALO in Q1 2026 and has held it in 2 quarters since. 369 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Yorktown Management & Research Company held 7,850 shares of Halozyme worth $614K as of Q2 2026.
  • Yorktown Management & Research Company bought 3,400 Halozyme shares in Q2 2026, an estimated $232K.
  • Halozyme made up 0.38% of Yorktown Management & Research Company's portfolio in Q2 2026, its #93 holding.
  • Yorktown Management & Research Company first reported a position in Halozyme in Q1 2026 and has held it in 2 quarters since.
  • 369 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.